Shukra Pharmaceuticals Ltd

NSE: SHUKRAPHAR · BSE: 524632 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹68.97
Market cap: ₹3,032 Cr
Revenue (annual): ₹56.73 Cr
Net profit (annual): ₹22.06 Cr
P/E (TTM): 89.2×Sector 47.4×
Promoter holding: 51.15%+0.19% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 5 Other Announcement 4 Board Meeting Date 4 Financial Results 3 Fund Raise 2 Capital Structure Change 2 Board Meeting Outcome 2 SME to Main Board Migration 1 Merger & Restructuring 1 Management Change 1 Dividend 1 Debt & Borrowing 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

10 Jun 2026 18:58 IST BSE

Fund Raise

Shukra Pharmaceuticals Fund Raise of ₹16.51 Cr

Shukra Pharmaceuticals seeks fresh approval for a Rs.16.51 Crore preferential warrant issue to promoters. The move aims to raise capital while complying with SEBI ICDR regulations.

Value: ₹16.51 Cr

Read the filing ↗

7 May 2026 22:38 IST BSE

Fund Raise

Shukra Pharmaceuticals Fund Raise of ₹3.95 Cr

Shukra Pharmaceuticals confirmed zero deviation in utilizing ₹3.95 Crore raised via convertible warrants. The funds support working capital, debt repayment, and capital expenditure.

Value: ₹3.95 Cr

Read the filing ↗